New York

Epidemiological Brief

As of 27 July 2026, New York is classified at LOW epidemic risk (composite score 15.2). Influenza-like illness is the primary signal at 5.8% ILI prevalence (20.9% adjusted), above typical July baseline, suggesting sustained community influenza circulation through the summer. Pertussis incidence stands at 1.36 cases per 100,000. COVID-19 activity is low at 0.37 cases per 100,000; partial wastewater data from the NYC DOHMH sensor network supplement clinical surveillance. Mpox is detected at a low level (0.06 cases per 100,000). Measles incidence is minimal at 0.08 cases per 100,000. Dengue cases are travel-associated (0.06 cases per 100,000) with no local transmission. Wastewater-based epidemiology is actively monitoring COVID-19 via both the NYC DOHMH network and ATCP-73RE. No international arrivals were recorded in the current OpenSky data cycle, though New York's overall travel volume warrants continued importation vigilance. Dry conditions (23 °C, 61% humidity, no precipitation) pose minimal vector-borne risk. Public health priorities include influenza rapid testing at fan medical posts, pertussis outbreak readiness in coordination with NYC DOHMH and New Jersey health authorities, MMR verification at international arrival points, standard mpox clinical pathways at all event medical facilities, and continued multi-agency wastewater signal monitoring.

Model SCEME v3.1 · Updated July 27, 2026

Please consult a local doctor or pharmacist for guidance and medication.